Analyst Price Targets — GLPG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 7:21 pm | Brian Abrahams | RBC Capital | $33.00 | $34.36 | StreetInsider | Galapagos NV (GLPG) PT Raised to $33 at RBC Capital |
| October 22, 2025 12:22 pm | Brian Abrahams | RBC Capital | $28.00 | $31.43 | TheFly | Galapagos price target raised to $28 from $27 at RBC Capital |
| October 21, 2025 8:08 pm | — | Leerink Partners | $40.00 | $31.43 | TheFly | Galapagos upgraded to Outperform from Market Perform at Leerink |
| July 7, 2021 12:00 am | David Evans | Kepler Capital | $85.92 | $66.78 | Investing | Kepler Capital Stick to Their Hold Rating for Galapagos |
| May 9, 2021 12:00 am | Derek Archila | Wells Fargo | $97.00 | $73.54 | StreetInsider | Galapagos NV (GLPG) PT Raised to $97 at Stifel |
| April 12, 2021 12:00 am | Laura Sutcliffe | UBS | $83.74 | $77.39 | TheFly | Galapagos price target raised to EUR 77 from EUR 75 at UBS |
Latest News for GLPG
Galapagos NV (GLPG) Q4 2025 Earnings Call Transcript
Mechelen, Belgium; February 23, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today reported its financial results for the full year 2025 and provided an update on the fourth quarter 2025 and its year-to-date performance.
Mechelen, Belgium ; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America.
U.S. stock futures were mixed on Tuesday after a higher close on Monday.
U.S. stock futures up, focus on AngioDynamics, Microchip Tech, AAR earnings. Galapagos to wind down cell therapy.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for GLPG.
Senate Trading
No Senate trades found for GLPG.
U.S. House Trading
No House trades found for GLPG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.